This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Watson gets rights to Itero's rFSH for female infertility
20 Aug 2010
Watson Pharmaceuticals Inc. (generics and branded urology and women's health products) has received exclusive worldwide rights to Itero Biopharmaceuticals Inc.'s (protein therapeutics) recombinant follicle-stimulating hormone (rFSH), which is in preclinical studies for female infertility.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?